CUSTOM Study: Mevacor OTC Data May Be Boon For Switch Prospects

Former Nonprescription Drugs Advisory Committee Chair and J&J/Merck consultant Brass says Mevacor actual use study data support safe use of OTC lovastatin. Almost half of high-risk patients reported using the nonprescription statin after discussing it with a doctor.